The effect of gastrointestinal hormones on the incorporation of tritiated thymidine in the pancreatic adenocarcinoma cell line (WD PaCa)
- PMID: 2600453
- DOI: 10.1007/BF02924419
The effect of gastrointestinal hormones on the incorporation of tritiated thymidine in the pancreatic adenocarcinoma cell line (WD PaCa)
Abstract
In view of the trophic action of gastrointestinal hormones on the exocrine pancreas, the effects of secretin, octapeptide of cholecystokinin (CCK-8), and desglugastrin on the growth of hamster pancreatic well differentiated adenocarcinoma were investigated in vitro. Desglugastrin exhibited the greatest effect on thymidine incorporation into these cells after a lag period of 96 h. Doses of desglugastrin in the range from 30 to 270 ng/mL caused a significant and dose-dependent increase in thymidine incorporation. Higher doses of this peptide led to a decreased response. Secretin also increased thymidine incorporation, but the response was less than that induced by gastrin. Prolonged incubation with secretin for 96 h increased tritiated thymidine incorporation in a log-dose fashion in the range of 30 to 270 ng/mL. Doses of CCK-8 in the range of 90 to 810 ng/mL significantly increased thymidine incorporation after 48 h of incubation. Following 72 h of incubation, only the dose of 270 ng/mL continued to exhibit a significant stimulation. Our study suggests that the gastrointestinal hormones could directly increase the growth of pancreatic carcinoma cells, act synergistically with endogenous growth factors, or stimulate the local production of these factors. In any event, our results that gastrin, secretin, and CCK can stimulate the growth of pancreatic ductal tumor cells in tissue cultures, support earlier findings on normal and malignant pancreatic parenchyma.
Similar articles
-
Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro.Am J Physiol. 1986 Oct;251(4 Pt 1):G487-94. doi: 10.1152/ajpgi.1986.251.4.G487. Am J Physiol. 1986. PMID: 3020992
-
Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.Pancreas. 1991 Jan;6(1):23-30. doi: 10.1097/00006676-199101000-00004. Pancreas. 1991. PMID: 1704631
-
Stimulation of DNA synthesis in pancreatic duct cells by gastrointestinal hormones: interaction with other growth factors.Pancreas. 1992;7(3):271-9. doi: 10.1097/00006676-199205000-00002. Pancreas. 1992. PMID: 1594548
-
Interaction between octapeptide-cholecystokinin, gastrin, and secretin on cat gallbladder in vitro.Am J Physiol. 1975 Nov;229(5):1311-5. doi: 10.1152/ajplegacy.1975.229.5.1311. Am J Physiol. 1975. PMID: 1200149
-
Potentiating effect of CCK and secretin on rat exocrine pancreas and its cholinergic dependence.Pancreas. 1991 Sep;6(5):603-8. doi: 10.1097/00006676-199109000-00015. Pancreas. 1991. PMID: 1719526
Cited by
-
Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.J Clin Endocrinol Metab. 2007 Nov;92(11):4394-402. doi: 10.1210/jc.2007-0986. Epub 2007 Aug 21. J Clin Endocrinol Metab. 2007. PMID: 17711922 Free PMC article.
-
On the role of cholecystokinin in pancreatic cancer.Int J Pancreatol. 1995 Apr;17(2):121-38. doi: 10.1007/BF02788530. Int J Pancreatol. 1995. PMID: 7622936 Review. No abstract available.
-
Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas.Br J Cancer. 1997;75(10):1467-73. doi: 10.1038/bjc.1997.251. Br J Cancer. 1997. PMID: 9166939 Free PMC article.
-
Effects of gastric fundectomy and antrectomy on the exocrine pancreas in the hamster.Int J Pancreatol. 1992 Oct;12(2):139-44. doi: 10.1007/BF02924637. Int J Pancreatol. 1992. PMID: 1460328
-
Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.Am J Pathol. 2005 Oct;167(4):959-68. doi: 10.1016/S0002-9440(10)61186-8. Am J Pathol. 2005. PMID: 16192632 Free PMC article.